Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

NCT00400205 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Safety reasons

Conditions

Squamous Cell Carcinoma
Oral Cancer

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
DRUG: 5-fluorouracil

Sponsor

Emory University

Collaborators

[object Object]